Thus, we can hypothesize that the currently observed anti-inflammatory effect of hCTS seen during the reactivation of colitis occurs through the downregulation of the M1 population and potentially through the activation of STAT-3 phosphorylation. The gene discussed is STAT3; the disease is colitis.